These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15228070)

  • 21. [Hemorrhagic accidents with low molecular weight heparin: 15 cases].
    Bonnet F; Morlat P; de Witte S; Bernard N; Lacoste D; Beylot J
    Rev Med Interne; 2001 Aug; 22(8):761-3. PubMed ID: 11534365
    [No Abstract]   [Full Text] [Related]  

  • 22. Prophylaxis for thromboembolism in hospitalized medical patients.
    Famularo G; Minisola G; De Simone C
    N Engl J Med; 2007 Jul; 357(3):305; author reply 305-6. PubMed ID: 17644834
    [No Abstract]   [Full Text] [Related]  

  • 23. Deep vein thrombosis and cancer: survival, recurrence, and anticoagulant choices.
    Lee AY
    Dis Mon; 2005; 51(2-3):150-7. PubMed ID: 15900267
    [No Abstract]   [Full Text] [Related]  

  • 24. Low-molecular-weight heparin for deep vein thrombosis prophylaxis in foot and ankle surgery: a review.
    Cirlincione AS; Mendicino R; Catanzariti AR; Grossman J
    J Foot Ankle Surg; 2001; 40(2):96-100. PubMed ID: 11324676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. So, does low-molecular-weight heparin cause less heparin-induced thrombocytopenia than unfractionated heparin or not?
    Warkentin TE; Greinacher A
    Chest; 2007 Oct; 132(4):1108-10. PubMed ID: 17934108
    [No Abstract]   [Full Text] [Related]  

  • 26. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
    Lu X; Lin J
    BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty.
    Jameson SS; Rymaszewska M; Hui AC; James P; Serrano-Pedraza I; Muller SD
    J Bone Joint Surg Am; 2012 Sep; 94(17):1554-8. PubMed ID: 22832942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DVT prevention. Low-molecular-weight heparin is a viable option.
    Benton L
    Am J Nurs; 2000 Feb; 100(2):84. PubMed ID: 10712165
    [No Abstract]   [Full Text] [Related]  

  • 29. [Priapism and low-molecular-weight heparin. Case report].
    Carmoi T; Skopinski S; Constans J; Vahedy A; Conri C
    Rev Med Interne; 2001 Oct; 22(10):1002-3. PubMed ID: 11695312
    [No Abstract]   [Full Text] [Related]  

  • 30. Prolonged thromboprophylaxis with low molecular weight heparin after major abdominal surgery.
    Rasmussen MS
    Curr Opin Pulm Med; 2007 Sep; 13(5):389-92. PubMed ID: 17940482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Think of HIT when thrombosis follows heparin.
    Warkentin TE
    Chest; 2006 Sep; 130(3):631-2. PubMed ID: 16963651
    [No Abstract]   [Full Text] [Related]  

  • 32. Ximelagatran for prevention and treatment of venous thromboembolism.
    Kwok L; Boucher M
    Issues Emerg Health Technol; 2004 Jun; (57):1-4. PubMed ID: 15214359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strength of evidence for low-molecular-weight heparin.
    Alonso-Ortiz del Rio C; Romero-Alonso A; Marin-Leon I; Rincon-Gomez M
    Chest; 2002 Jun; 121(6):2078; author reply 2078-9. PubMed ID: 12065386
    [No Abstract]   [Full Text] [Related]  

  • 34. Low molecular weight heparin in management and prevention of portal vein thrombosis.
    Lisman T
    Thromb Res; 2014 Oct; 134(4):761-2. PubMed ID: 25179517
    [No Abstract]   [Full Text] [Related]  

  • 35. New strategies in anti-thrombotic therapy offer efficacy, cost savings.
    Clin Resour Manag; 2001 Oct; 2(10):155-8, 145. PubMed ID: 11682931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG; Lieberman JR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Low-molecular weight heparins in pregnancy].
    Aguilera C; Vallano A
    Med Clin (Barc); 2002 May; 118(16):634-5. PubMed ID: 12028918
    [No Abstract]   [Full Text] [Related]  

  • 38. Deep venous thrombosis: thinking inside out.
    Liebowitz RS
    Arch Intern Med; 1998 Oct; 158(18):1964. PubMed ID: 9778193
    [No Abstract]   [Full Text] [Related]  

  • 39. The treatment of deep venous thrombosis, including the newer agents.
    Rectenwald JE; Wakefield TW
    Dis Mon; 2005; 51(2-3):104-11. PubMed ID: 15900261
    [No Abstract]   [Full Text] [Related]  

  • 40. Monitoring low molecular weight heparins.
    Garon JE
    Clin Leadersh Manag Rev; 2003; 17(1):47-50. PubMed ID: 12592880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.